Clinical Trial Update: A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjunctive perampanel for primary generalized tonic-clonic seizures has completed; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Generalized Tonic-clonic Seizures

Drugs mentioned

• Perampanel (perampanel)

Snippet

Sponsor: Eisai Inc. | Conditions: Seizure Disorder Generalized Tonic Clonic | Phase 3 | Status: COMPLETED | Results posted: 2016-01-11